ArticlePharmacology research & perspectives2023

Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways.

Antonio González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.